Immunovant, Inc.
IMVT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$127 | -$121 | -$106 | -$111 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $12 | $12 |
| Change in WC | $11 | -$15 | -$16 | -$1 |
| Other Non-Cash | $13 | $19 | $0 | $0 |
| Operating Cash Flow | -$103 | -$117 | -$111 | -$100 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $25 | $3 | $450 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1 | $2 |
| Financing Cash Flow | $25 | $3 | $451 | $2 |
| Forex Effect | $1 | -$1 | -$0 | -$0 |
| Net Chg. in Cash | -$77 | -$115 | $339 | -$98 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $599 | $714 | $375 | $473 |
| End Cash | $522 | $599 | $714 | $375 |
| Free Cash Flow | -$103 | -$117 | -$111 | -$101 |